S.1664 - Prescription Drug Price Reporting Act116th Congress (2019-2020) |
|Sponsor:||Sen. Scott, Rick [R-FL] (Introduced 05/23/2019)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||Senate - 05/23/2019 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed Senate
- Passed House
- To President
- Became Law
Summary: S.1664 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in Senate (05/23/2019)
Prescription Drug Price Reporting Act
This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.
HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.